Tazbentetol (INN; developmental code name SPG302) is a synaptogenic drug which is under development for the treatment of Alzheimer's disease, amyotrophic lateral sclerosis (ALS), schizophrenia, diabetic retinopathy, and glaucoma.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.